Observational studyJournal of cancer research and clinical oncology2018

Trabectedin plus pegylated liposomal doxorubicin (PLD) for patients with platinum-sensitive recurrent ovarian cancer: a prospective, observational, multicenter study.

Ingo B Runnebaum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.